A new “high efficacy” malaria vaccine co-developed by the Serum Institute of India and the University of Oxford was officially rolled out on Monday when Cote d’Ivoire in West Africa became the first country to begin administering R21/Matrix-M. In total, 15 African countries are expected to introduce malaria vaccines with Gavi support in 2024, and countries plan to reach around …
